Statistik Asas
| CIK | 1856084 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Ridgetech, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan senarai kronologi lengkap bagi Pemfailan SEC, tidak termasuk pemfailan pemilikan yang kami sediakan di tempat lain.
| July 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2025 Commission File Number: 001-40724 RIDGETECH, INC. (Translation of registrant’s name into English) 5th Floor, Building 6, No. 100, 18th Street, Baiyang Sub-district, Qiantang District, Ha |
|
| July 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal year ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1 |
|
| July 28, 2025 |
Exhibit 12.1 CERTIFICATION BY THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Ming Zhao, certify that: 1. I have reviewed this annual report on Form 20-F of Ridgetech, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of th |
|
| July 28, 2025 |
Consent of Independent Registered Public Accounting Firm Exhibit 15.1 Consent of Independent Registered Public Accounting Firm Ridgetech Inc. We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-259692 and No. 333-269182) and S-8 (No. 333-264505, No. 333-268809 and No. 333-277849) of Ridgetech, Inc. of our report dated July 28, 2025, relating to the consolidated financial statements and schedules for th |
|
| July 28, 2025 |
Exhibit 4.40 Hangzhou Jiuzhou Grand Pharmacy Chain Co., Ltd. 2025 Procurement Agreement February 28, 2025 Procurement Agreement Supplier: Zhejiang Jiuxin Medicine Co., Ltd. Legal representative: Wang Lufen Warehouse address: [***] Buyer: Hangzhou Jiuzhou Grand Pharmacy Chain Co., Ltd. Legal representative: Qi Li Company address: [***] WHEREAS The Supplier is an enterprise engaged in the wholesale |
|
| July 28, 2025 |
Exhibit 2.2 Description of Rights of Each Class of Securities Registered under Section 12 of the Securities Exchange Act of 1934 (the “Exchange Act”) The following securities are registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended: Title of Each Class Trading Symbol Name of Each Exchange on Which Registered ordinary share, par value US$0.001 per share RDGT NASDAQ C |
|
| July 28, 2025 |
Ridgetech, Inc. Reports Fiscal Year 2025 Financial Results Exhibit 99.1 Ridgetech, Inc. Reports Fiscal Year 2025 Financial Results HANGZHOU, China, July 28, 2025 /PRNewswire/ - Ridgetech, Inc. (Nasdaq: RDGT) (“Ridgetech” or the “Company”), a wholesale distributor of pharmaceutical and other healthcare products in China, today announced its financial results for the fiscal year ended March 31, 2025. Mr. Frank Zhao, Interim Chief Executive Officer and Chief |
|
| July 28, 2025 |
Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual report on Form 20-F for the year ended March 31, 2025 (the “Report”) of Ridgetech, Inc. (the “Company”) as filed with the Securities and Exchange Commission on the date hereof, I, Ming Zhao, Interim Chief Executive Officer and Chief Finan |
|
| June 4, 2025 |
Exhibit 3.1 The Companies Act (Revised) Company Limited by Shares THE FOURTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF RIDGETECH, INC. (adopted by a Special Resolution of the Shareholders of the Company passed on 25 February 2025 and effective 28 May 2025) Grand Cayman Cayman Islands conyers.com www.verify.gov.ky File#: 373821 THE COMPANIES ACT (REVISED) EXEMPTED COMPANY LIMIT |
|
| June 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2025 Commission File Number: 001-40724 RIDGETECH, INC. (Translation of registrant’s name into English) 5th Floor, Building 6, No. 100, 18th Street, Baiyang Sub-district, Qiantang District, Ha |
|
| March 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2025 Commission File Number: 001-40724 RIDGETECH, INC. (Translation of registrant’s name into English) 4th Floor, Building 5, Renxin Yaju, Gong Shu District, Hangzhou City, Zhejiang Province |
|
| February 5, 2025 |
Exhibit 99.1 CHINA JO-JO DRUGSTORES, INC. 4th Floor, Building 5, Renxin Yaju, Gong Shu District Hangzhou City, Zhejiang Province, P. R. China, 310014 Telephone: +86-571-88219579 NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON FEBRUARY 25, 2025 (or any adjournment or postponement thereof) TO THE SHAREHOLDERS OF CHINA JO-JO DRUGSTORES, INC.: Notice is hereby given that an Annual Gener |
|
| February 5, 2025 |
Exhibit 99.3 CHINA JO-JO DRUGSTORES, INC CONTROL ID: REQUEST ID: IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS FOR THE ANNUAL GENERAL MEETING OF SHAREHOLDERS DATE: TUESDAY, FEBRUARY 25, 2025 TIME: 9:00 P.M. EASTERN TIME LOCATION: 4TH FLOOR, BUILDING 5, RENXIN YAJU, GONG SHU DISTRICT, HANGZHOU CITY, ZHEJIANG PROVINCE, P. R. CHINA, 310014 HOW TO REQUEST PAPER COPIES OF OUR MATERIALS |
|
| February 5, 2025 |
Exhibit 99.2 CHINA JO-JO DRUGSTORES INC THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS ANNUAL GENERAL MEETING OF SHAREHOLDERS – FEBRUARY 25, 2025 AT 9.00 P.M. E.T. CONTROL ID: REQUEST ID: The undersigned shareholder of China Jo-Jo Drugstores, Inc., a Cayman Islands exempted company (the “Company”), hereby acknowledges receipt of the Notice of Annual General Meeting of Shareholders and |
|
| February 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. |
|
| February 3, 2025 |
Exhibit 10.1 EQUITY EXCHANGE AGREEMENT by and among CHINA JO-JO DRUGSTORES, INC., as the Purchaser, RIDGELINE INTERNATIONAL LIMITED, as the Company and LINGTAO KONG, as the Seller Dated as of January 31, 2025 Table of Contents Page ARTICLE I THE SHARE EXCHANGE 2 1.1 Purchase and Sale of Shares 2 1.2 Consideration 2 1.3 Company Shareholder Consent 2 ARTICLE II CLOSING 2 2.1 Closing 2 ARTICLE III RE |
|
| February 3, 2025 |
Exhibit 10.2 Equity EXCHANGE AGREEMENT This Equity Exchange Agreement (this “Agreement”) is made and entered into as of January 31, 2025, by and among (i) China Jo-Jo Drugstores, Inc., a Cayman Islands exempted company (“CJJD”), (ii) Renovation Investment (Hong Kong) Co., Ltd. (香港創新投資有限公司), a Hong Kong private limited company (“Renovation”, together with CJJD, the “CJJD Parties”), (iii) Lei Liu, t |
|
| February 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2025 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. |
|
| February 3, 2025 |
Exhibit 99.1 China Jo-Jo Drugstores Announces Strategic Business Restructuring to Strengthen Wholesale Business for Greater Profitability and Growth HANGZHOU, China, February 3, 2025 /PRNewswire/ - China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) (“Jo-Jo Drugstores” or the “Company”), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and health |
|
| January 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January, 2025 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. |
|
| November 14, 2024 |
CJJD / China Jo-Jo Drugstores, Inc. / Liu Lei - AMENDMENT NO. 3 TO SCHEDULE 13D Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 3) CHINA JO-JO DRUGSTORES, INC. (successor issuer pursuant to Rule 12g-3 under the Securities Exchange Act of 1934 to China Jo-Jo Drugstores, Inc., a Nevada corporation) (Name of Issuer) Ordinary Shares, par value $0.24 per share (Title of Class of Securities) G2124G120 |
|
| November 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2024 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) 4th Floor, Building 5, Renxin Yaju, Gong Shu District Hangzhou City, Zh |
|
| October 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2024 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) 4th Floor, Building 5, Renxin Yaju, Gong Shu District Hangzhou City, Zhe |
|
| September 3, 2024 |
CJJD / China Jo-Jo Drugstores, Inc. / Liu Lei - AMENDMENT NO. 2 TO SCHEDULE 13D Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 2) CHINA JO-JO DRUGSTORES, INC. (successor issuer pursuant to Rule 12g-3 under the Securities Exchange Act of 1934 to China Jo-Jo Drugstores, Inc., a Nevada corporation) (Name of Issuer) Ordinary Shares, par value $0.24 per share (Title of Class of Securities) G2124G120 |
|
| July 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2024 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) 4th Floor, Building 5, Renxin Yaju, Gong Shu District Hangzhou City, Zhejia |
|
| July 30, 2024 |
China Jo-Jo Drugstores Reports Fiscal Year 2024 Financial Results Exhibit 99.1 China Jo-Jo Drugstores Reports Fiscal Year 2024 Financial Results HANGZHOU, China, July 30, 2024 /PRNewswire/ - China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) (“Jo-Jo Drugstores” or the “Company”), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced its financial results for the fis |
|
| July 30, 2024 |
Exhibit 12.1 CERTIFICATION BY THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Lei Liu, certify that: 1. I have reviewed this annual report on Form 20-F of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in |
|
| July 30, 2024 |
Exhibit 12.2 CERTIFICATION BY THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Ming Zhao, certify that: 1. I have reviewed this annual report on Form 20-F of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, i |
|
| July 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal year ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1 |
|
| July 30, 2024 |
China Jo-Jo Drugstores, Inc. COMPENSATION RECOVERY POLICY Effective December 1, 2023 Exhibit 97.1 China Jo-Jo Drugstores, Inc. COMPENSATION RECOVERY POLICY Effective December 1, 2023 In accordance with Section 10D of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), Exchange Act Rule 10D-1, and rule 5608 of the Nasdaq rules (“Nasdaq Rules”), the rules where the securities of China Jo-Jo Drugstores, Inc. (the “Company”) are listed. The Company’s Board of Directo |
|
| July 30, 2024 |
Consent of Independent Registered Public Accounting Firm Exhibit 15.1 Consent of Independent Registered Public Accounting Firm China Jo-Jo Drugstores, Inc. We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-259692 and No. 269182) and S-8 (No. 268809 and No. 277849) of China Jo-Jo Drugstores, Inc. of our report dated July 30, 2024, relating to the consolidated financial statements and schedules for the |
|
| July 30, 2024 |
Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual report on Form 20-F for the year ended March 31, 2024 (the “Report”) of China Jo-Jo Drugstores, Inc. (the “Company”) as filed with the Securities and Exchange Commission on the date hereof, we, Lei Liu, Chief Executive Officer, and Ming Z |
|
| June 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2024 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) 4th Floor, Building 5, Renxin Yaju, Gong Shu District Hangzhou City, Zhejia |
|
| June 11, 2024 |
Exhibit 10.1 SHARE PURCHASE AGREEMENT This SHARE PURCHASE AGREEMENT (the “Agreement”) is made as of June 11, 2024 by and among China Jo-Jo Drugstores, Inc., a Cayman Islands exempted company (the “Company”), the purchasers listed on Schedule A hereto (the “Schedule of Purchasers”), each of which is herein referred to as a “Purchaser” and collectively, the “Purchasers” and, solely for the limited a |
|
| June 11, 2024 |
CHINA JO-JO DRUGSTORES, INC. 1,980,000 Shares of Ordinary Shares PROSPECTUS SUPPLEMENT Filed pursuant to Rule 424(b)(5) (To Prospectus effective as of December 19, 2022) File No. |
|
| June 11, 2024 |
China Jo-Jo Drugstores Announces $3.37 Million Registered Direct Offering Exhibit 99.1 China Jo-Jo Drugstores Announces $3.37 Million Registered Direct Offering HANGZHOU, China, June 11, 2024 /PRNewswire/ - China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) (“Jo-Jo Drugstores” or the “Company”), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into |
|
| May 31, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) 4th Floor, Building 5, Renxin Yaju, Gong Shu District Hangzhou City, Zhejian |
|
| May 31, 2024 |
China Jo-Jo Drugstores Announces Changes to Board of Directors Exhibit 99.1 China Jo-Jo Drugstores Announces Changes to Board of Directors HANGZHOU, China, May 31, 2024]/PRNewswire/ - China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) (“Jo-Jo Drugstores” or the “Company”), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that Ms. Pingfan Wu has resigned from |
|
| May 10, 2024 |
CHINA JO-JO DRUGSTORES, INC. 1,610,000 Shares of Ordinary Shares PROSPECTUS SUPPLEMENT Filed pursuant to Rule 424(b)(5) (To Prospectus effective as of December 19, 2022) File No. |
|
| May 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2024 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) 4th Floor, Building 5, Renxin Yaju, Gong Shu District Hangzhou City, Zhejian |
|
| May 10, 2024 |
Exhibit 10.1 SHARE PURCHASE AGREEMENT This SHARE PURCHASE AGREEMENT (the “Agreement”) is made as of May 10, 2024 by and among China Jo-Jo Drugstores, Inc., a Cayman Islands exempted company (the “Company”), the purchasers listed on Schedule A hereto (the “Schedule of Purchasers”), each of which is herein referred to as a “Purchaser” and collectively, the “Purchasers” and, solely for the limited an |
|
| May 10, 2024 |
China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering Exhibit 99.1 China Jo-Jo Drugstores Announces $2.74 Million Registered Direct Offering HANGZHOU, China, May 10, 2024 /PRNewswire/ — China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) (“Jo-Jo Drugstores” or the “Company”), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into d |
|
| April 29, 2024 |
CHINA JO-JO DRUGSTORES, INC. 900,000 Shares of Ordinary Shares PROSPECTUS SUPPLEMENT Filed pursuant to Rule 424(b)(5) (To Prospectus effective as of December 19, 2022) File No. |
|
| April 29, 2024 |
Exhibit 3.1 Certified A True Copy of Conyers Trust Company (Cayman) Limited as Registered Office Mesha Christian Authorised Signatory For and on Behalf of Conyers Trust Company (Cayman) Limited Dated: 6 March 2024 The Companies Act (Revised) Company Limited by Shares THE THIRD AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF CHINA JO-JO DRUGSTORES, INC. (adopted by a Special Resoluti |
|
| April 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) 4th Floor, Building 5, Renxin Yaju, Gong Shu District Hangzhou City, Zheji |
|
| April 29, 2024 |
Exhibit 10.1 SHARE PURCHASE AGREEMENT This SHARE PURCHASE AGREEMENT (the “Agreement”) is made as of April 29, 2024 by and among China Jo-Jo Drugstores, Inc., a Cayman Islands exempted company (the “Company”), the purchasers listed on Schedule A hereto (the “Schedule of Purchasers”), each of which is herein referred to as a “Purchaser” and collectively, the “Purchasers” and, solely for the limited |
|
| April 29, 2024 |
China Jo-Jo Drugstores Announces $1.53 Million Registered Direct Offering Exhibit 99.1 China Jo-Jo Drugstores Announces $1.53 Million Registered Direct Offering HANGZHOU, China, April 29, 2024 /PRNewswire/ - China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into |
|
| April 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April 2024 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) 4th Floor, Building 5, Renxin Yaju, Gong Shu District, Hangzhou City, Zhej |
|
| April 16, 2024 |
CJJD / China Jo-Jo Drugstores, Inc. / Liu Lei - AMENDMENT NO. 1 TO SCHEDULE 13D Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1) CHINA JO-JO DRUGSTORES, INC. (successor issuer pursuant to Rule 12g-3 under the Securities Exchange Act of 1934 to China Jo-Jo Drugstores, Inc., a Nevada corporation) (Name of Issuer) Ordinary Shares, par value $0.24 per share (Title of Class of Securities) G2124G120 |
|
| March 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March, 2024 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. |
|
| March 19, 2024 |
China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement Exhibit 99.1 China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement HANGZHOU, China, March 19, 2024 /PRNewswire/ - China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it receiv |
|
| March 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2024 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) 4th Floor, Building 5, Renxin Yaju, Gong Shu District, Hangzhou City, Zhej |
|
| March 12, 2024 |
Exhibit 107 Calculation of Filing Fee Tables S-8 (Form Type) China Jo-Jo Drugstores, Inc. |
|
| March 12, 2024 |
As filed with the Securities and Exchange Commission on March 12, 2024 As filed with the Securities and Exchange Commission on March 12, 2024 Registration No. |
|
| February 27, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February, 2024 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, |
|
| February 27, 2024 |
China Jo-Jo Drugstores, Inc. Announces 1-for-20 Reverse Stock Split Exhibit 99.1 China Jo-Jo Drugstores, Inc. Announces 1-for-20 Reverse Stock Split HANGZHOU, China, February 27, 2024 /PRNewswire/ – China Jo-Jo Drugstores, Inc. (the “Company”) (Nasdaq: CJJD), a Cayman Islands exempted company, reported that it expects to implement a 1-for-20 reverse stock split on its ordinary shares (“Ordinary Shares”) effective Friday, March 1, 2024, with trading to begin on a s |
|
| February 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2024 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Z |
|
| January 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January, 2024 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) Hai Wai Hai Tongxin Mansion Floor 6, Gong Shu District, Hangzhou City, |
|
| January 26, 2024 |
Exhibit 99.1 CHINA JO-JO DRUGSTORES, INC. Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City Zhejiang Province P. R. China, 310008 Telephone: +86-571-88219579 NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON FEBRUARY 22, 2024 (or any adjournment or postponement thereof) TO THE SHAREHOLDERS OF CHINA JO-JO DRUGSTORES, INC.: Notice is hereby given that an Extrao |
|
| January 26, 2024 |
Exhibit 99.2 CHINA JO-JO DRUGSTORES INC THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS EXTRAORDINARY GENERAL meeting OF SHAREHOLDERS – February 22, 2024 at 9:00 PM E.T. CONTROL ID: REQUEST ID: The undersigned shareholder of China Jo-Jo Drugstores, Inc., a Cayman Islands corporation (the “Company”), hereby acknowledges receipt of the Notice of Extraordinary General Meeting of Sharehold |
|
| December 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K/A REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, |
|
| December 14, 2023 |
China Jo-Jo Drugstores Granted A Second Extension to Meet Nasdaq Minimum Bid Price Requirement Exhibit 99.1 China Jo-Jo Drugstores Granted A Second Extension to Meet Nasdaq Minimum Bid Price Requirement HANGZHOU, China, December 14, 2023 /PRNewswire/ - China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) (the “Company”), a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that on December 13 |
|
| December 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2023 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Z |
|
| November 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November 2023 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Z |
|
| November 14, 2023 |
Exhibit 99.1 CHINA JO-JO DRUGSTORES, INC. Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City Zhejiang Province P. R. China, 310008 Telephone: +86-571-88219579 NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON November 16, 2023 TO THE SHAREHOLDERS OF CHINA JO-JO DRUGSTORES, INC.: The Annual General Meeting of the shareholders for the fiscal year ended March 31, 2023 ( |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November, 2023 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) Hai Wai Hai Tongxin Mansion Floor 6, Gong Shu District, Hangzhou City, |
|
| September 26, 2023 |
PROSPECTUS SUPPLEMENT Filed pursuant to Rule 424(b)(5) (To Prospectus dated December 19, 2022) File No. |
|
| September 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of September 2023 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, |
|
| September 26, 2023 |
Exhibit 10.2 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made as of September 26, 2023 by and among China Jo-Jo Drugstores, Inc., a Cayman Islands exempted company (the “Company”), and the purchasers listed on Schedule A hereto (the “Schedule of Purchasers”), each of which is herein referred to as a “Purchaser” and collectively, the “Purchasers.” WHEREAS, |
|
| September 26, 2023 |
China Jo-Jo Drugstores Announces $2.59 Million Registered Direct Offering Exhibit 99.1 China Jo-Jo Drugstores Announces $2.59 Million Registered Direct Offering HANGZHOU, China, September 26, 2023 /PRNewswire/ - China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) (“Jo-Jo Drugstores” or the “Company”), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered |
|
| September 26, 2023 |
CHINA JO-JO DRUGSTORES, INC. WARRANT TO PURCHASE ORDINARY SHARES Exhibit 10.1 CHINA JO-JO DRUGSTORES, INC. WARRANT TO PURCHASE ORDINARY SHARES No. OW- Issued on September 28, 2023 THIS ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [●] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after September 28, 2023 (the “ |
|
| June 16, 2023 |
Exhibit 99.1 China Jo-Jo Drugstores Announced Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency HANGZHOU, China, June 16, 2023 /PRNewswire/ - China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) (“Jo-Jo Drugstores” or the “Company”), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announ |
|
| June 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Zheji |
|
| June 15, 2023 |
Consent of Independent Registered Public Accounting Firm Exhibit 15.1 Consent of Independent Registered Public Accounting Firm China Jo-Jo Drugstores, Inc. Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District Hangzhou City, Zhejiang Province People’s Republic of China, 310008 We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-259692 and No. 333-269182) and S-8 (No. 333-264505 and No. 333-268809) of C |
|
| June 15, 2023 |
Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual report on Form 20-F for the year ended March 31, 2023 (the “Report”) of China Jo-Jo Drugstores, Inc. (the “Company”) as filed with the Securities and Exchange Commission on the date hereof, we, Lei Liu, President and Chief Executive Offic |
|
| June 15, 2023 |
Consent of Independent Registered Public Accounting Firm EX-15.2 8 f20f2023ex15-2chinajojo.htm CONSENT OF COMPANY'S CURRENT INDEPENDENT PUBLICLY REGISTERED ACCOUNTING FIRM, YCM CPA, INC Exhibit 15.2 Consent of Independent Registered Public Accounting Firm We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-259692, and No. 269182) and S-8 (No. 333-264505 and No. 268809) of China Jo-Jo Drugstores, Inc. o |
|
| June 15, 2023 |
Exhibit 12.1 CERTIFICATION BY THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Lei Liu, certify that: 1. I have reviewed this annual report on Form 20-F of China Jo-Jo Drugstores, Inc.; 2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in l |
|
| June 15, 2023 |
China Jo-Jo Drugstores Reports Fiscal Year 2023 Financial Results Exhibit 99.1 China Jo-Jo Drugstores Reports Fiscal Year 2023 Financial Results HANGZHOU, China, June 15, 2023 /PRNewswire/ - China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) (“Jo-Jo Drugstores” or the “Company”), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced its financial results for the fis |
|
| June 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of June 2023 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Zheji |
|
| June 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal year ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1 |
|
| June 15, 2023 |
Exhibit 12.2 CERTIFICATION BY THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Ming Zhao, certify that: 1. I have reviewed this annual report on Form 20-F of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, i |
|
| June 15, 2023 |
Exhibit 2.2 Description of Rights of Each Class of Securities Registered under Section 12 of the Securities Exchange Act of 1934 (the “Exchange Act”) The following securities are registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended: Title of Each Class Trading Symbol Name of Each Exchange on Which Registered ordinary share, par value US$0.012 per share CJJD NASDAQ C |
|
| February 14, 2023 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* China Jo-Jo Drugstores, Inc. (successor issuer pursuant to Rule 12g-3 under the Securities Exchange Act of 1934 to China Jo-Jo Drugstores, Inc., a Nevada corporation) (Name of Issuer) Ordinary Shares, par value $0.012 per share (Title of Class of Securities) G2124G1 |
|
| January 23, 2023 |
China Jo-Jo Drugstores, Inc. Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City People’s Republic of China 310008 January 23, 2023 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Trade and Services 100 F Street, NE Washington, D.C. 20549 Attention: Cara Wirth Re: China Jo-Jo Drugstores, Inc. Registration Statement on Form F-3 File No. 3 |
|
| January 23, 2023 |
PROSPECTUS SUPPLEMENT Filed pursuant to Rule 424(b)(5) (To Prospectus dated December 19, 2022) File No. |
|
| January 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January, 2023 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) Hai Wai Hai Tongxin Mansion Floor 6, Gong Shu District, Hangzhou City, |
|
| January 20, 2023 |
China Jo-Jo Drugstores Announces $2.625 Million Registered Direct Offering Exhibit 99.1 China Jo-Jo Drugstores Announces $2.625 Million Registered Direct Offering HANGZHOU, China, January 20, 2023 /PRNewswire/ - China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) (“Jo-Jo Drugstores” or the “Company”), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered i |
|
| January 20, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2023 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Zh |
|
| January 20, 2023 |
Exhibit 10.2 CHINA JO-JO DRUGSTORES, INC. WARRANT TO PURCHASE ORDINARY SHARES No. OW- Issued on January 24, 2023 THIS ORDINARY SHARE PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [●] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after January 24, 2023 (the “Init |
|
| January 20, 2023 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made as of January 20, 2023 by and among China Jo-Jo Drugstores, Inc., a Cayman Islands exempted company (the “Company”), and the purchasers listed on Schedule A hereto (the “Schedule of Purchasers”), each of which is herein referred to as a “Purchaser” and collectively, the “Purchasers.” WHEREAS, su |
|
| January 11, 2023 |
As filed with the Securities and Exchange Commission on January 11, 2023 As filed with the Securities and Exchange Commission on January 11, 2023 Registration No. |
|
| January 11, 2023 |
Exhibit 107 Calculation of Filing Fee Tables F-3 (Form Type) China Jo-Jo Drugstores, Inc. |
|
| December 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December, 2022 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) Hai Wai Hai Tongxin Mansion Floor 6, Gong Shu District, Hangzhou City, |
|
| December 15, 2022 |
As filed with the Securities and Exchange Commission on December 15, 2022 As filed with the Securities and Exchange Commission on December 15, 2022 Registration No. |
|
| December 15, 2022 |
China Jo-Jo Drugstores, Inc. Second Amended and Restated 2010 Equity Incentive Plan Exhibit 10.1 CHINA JO-JO DRUGSTORES, INC. SECOND AMENDED AND RESTATED 2010 EQUITY INCENTIVE PLAN 1. ESTABLISHMENT OF PLAN; DEFINITIONS 1.1 Purpose. The purpose of the China Jo-Jo Drugstores, Inc. Second Amended and Restated 2010 Equity Incentive Plan is to encourage certain officers, employees, directors, and consultants of China Jo-Jo Drugstores, Inc., a Cayman Islands exempted company (the “Comp |
|
| December 15, 2022 |
CORRESP 1 filename1.htm China Jo-Jo Drugstores, Inc. Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City People’s Republic of China 310008 December 15, 2022 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Trade and Services 100 F Street, NE Washington, D.C. 20549 Attention: Brian Fetterolf Re: China Jo-Jo Drugstores, Inc. Registration St |
|
| December 15, 2022 |
As filed with the Securities and Exchange Commission on December 15, 2022 As filed with the Securities and Exchange Commission on December 15, 2022 Registration No. |
|
| December 15, 2022 |
Exhibit 107 Calculation of Filing Fee Tables S-8 (Form Type) China Jo-Jo Drugstores, Inc. |
|
| December 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2022 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Z |
|
| November 23, 2022 |
CORRESP 1 filename1.htm China Jo-Jo Drugstores Inc. Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Zhejiang Province People’s Republic of China, 310008 November 23, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services 100 F Street, N.E Washington, DC 20549 Attn: Brian Fetterolf & Lilyanna Peyser Re: China |
|
| November 23, 2022 |
As filed with the Securities and Exchange Commission on November 23, 2022 As filed with the Securities and Exchange Commission on November 23, 2022 Registration No. |
|
| November 3, 2022 |
Exhibit 99.2 CHINA JO-JO DRUGSTORES, INC. THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS ANNUAL GENERAL MEETING OF SHAREHOLDERS ? DECEMBER 2, 2022, AT 9:00 PM EASTERN TIME CONTROL ID: REQUEST ID: The undersigned shareholder of China Jo-Jo Drugstores, Inc., a Cayman Islands corporation, (the ?Company?), hereby acknowledges receipt of the Notice of Annual General Meeting of Shareholders |
|
| November 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of November, 2022 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant?s name into English) Hai Wai Hai Tongxin Mansion Floor 6, Gong Shu District, Hangzhou City, |
|
| November 3, 2022 |
Exhibit 99.1 CHINA JO-JO DRUGSTORES, INC. Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City Zhejiang Province P. R. China, 310008 Telephone: +86-571-88219579 NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON December 2, 2022 TO THE SHAREHOLDERS OF CHINA JO-JO DRUGSTORES, INC.: The Annual General Meeting of the shareholders for the fiscal year ended March 31, 2022 (t |
|
| October 19, 2022 |
CORRESP 1 filename1.htm China Jo-Jo Drugstores Inc. Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Zhejiang Province People’s Republic of China, 310008 October 19, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services 100 F Street, N.E Washington, DC 20549 Attn: Brian Fetterolf Re: China Jo-Jo Drugstores In |
|
| October 19, 2022 |
As filed with the Securities and Exchange Commission on October 19, 2022 As filed with the Securities and Exchange Commission on October 19, 2022 Registration No. |
|
| October 11, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of October 2022 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, |
|
| October 11, 2022 |
CHINA JO-JO DRUGSTORES, INC. WARRANT TO PURCHASE ORDINARY SHARES Exhibit 99.2 THE SECURITIES REPRESENTED HEREIN HAVE BEEN OFFERED AND SOLD IN AN ?OFFSHORE TRANSACTION? IN RELIANCE UPON REGULATION S AS PROMULGATED BY THE SECURITIES AND EXCHANGE COMMISSION. ACCORDINGLY, THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE ?SECURITIES ACT?) AND MAY NOT BE TRANSFERRED OTHER THAN IN ACCORDANCE WITH REGULATION |
|
| October 11, 2022 |
Exhibit 99.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?) is made as of October 6, 2022 by and among China Jo-Jo Drugstores, Inc., a Cayman Islands exempted company (the ?Company?), and the purchasers listed on Schedule A hereto (the ?Schedule of Purchasers?), each of which is herein referred to as a ?Purchaser? and collectively, the ?Purchasers.? WHEREAS, the |
|
| October 11, 2022 |
Exhibit 99.3 SHAREHOLDERS RIGHTS AGREEMENT This SHAREHOLDERS RIGHTS AGREEMENT (this ?Agreement?) is made and entered into as of October 6, 2022 by and among China Jo-Jo Drugstores, Inc., a Cayman Islands exempted company (the ?Company?), and each of the individuals and entities listed on Schedule A hereto (the ?Investors?). WHEREAS, the Investors have agreed to purchase ordinary shares of the Comp |
|
| September 15, 2022 |
As filed with the Securities and Exchange Commission on September 15, 2022 As filed with the Securities and Exchange Commission on September 15, 2022 Registration No. |
|
| September 15, 2022 |
CORRESP 1 filename1.htm China Jo-Jo Drugstores Inc. Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Zhejiang Province People’s Republic of China, 310008 September 15, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services 100 F Street, N.E Washington, DC 20549 Attn: Brian Fetterolf Re: China Jo-Jo Drugstores |
|
| August 5, 2022 |
As filed with the Securities and Exchange Commission on August 5, 2022 As filed with the Securities and Exchange Commission on August 5, 2022 Registration No. |
|
| August 5, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form F-3 (Form Type) China Jo-Jo Drugstores, Inc. |
|
| August 5, 2022 |
CORRESP 1 filename1.htm China Jo-Jo Drugstores Holdings, Inc. Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Zhejiang Province People’s Republic of China, 310008 August 5, 2022 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Trade &Services 100 F Street, N.E Washington, DC 20549 Attn: Stacey Peikin Re: China Jo-Jo Drugstor |
|
| August 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant?s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, |
|
| August 2, 2022 |
Exhibit 99.3 SHAREHOLDERS RIGHTS AGREEMENT This SHAREHOLDERS RIGHTS AGREEMENT (this “Agreement”) is made and entered into as of July 29, 2022 by and among China Jo-Jo Drugstores, Inc., a Cayman Islands exempted company (the “Company”), and each of the individuals and entities listed on Schedule A hereto (the “Investors”). WHEREAS, the Investors have agreed to purchase ordinary shares of the Compan |
|
| August 2, 2022 |
CHINA JO-JO DRUGSTORES, INC. WARRANT TO PURCHASE ORDINARY SHARES Exhibit 99.2 THE SECURITIES REPRESENTED HEREIN HAVE BEEN OFFERED AND SOLD IN AN “OFFSHORE TRANSACTION” IN RELIANCE UPON REGULATION S AS PROMULGATED BY THE SECURITIES AND EXCHANGE COMMISSION. ACCORDINGLY, THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “SECURITIES ACT”) AND MAY NOT BE TRANSFERRED OTHER THAN IN ACCORDANCE WITH REGULATION |
|
| August 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2022 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant’s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, |
|
| August 2, 2022 |
Exhibit 99.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made as of July 29, 2022 by and among China Jo-Jo Drugstores, Inc., a Cayman Islands exempted company (the “Company”), and the purchasers listed on Schedule A hereto (the “Schedule of Purchasers”), each of which is herein referred to as a “Purchaser” and collectively, the “Purchasers.” WHEREAS, the p |
|
| July 28, 2022 |
Section 302 Certification by the Corporation’s Chief Financial Officer * Exhibit 12.2 CERTIFICATION BY THE PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Ming Zhao, certify that: 1. I have reviewed this annual report on Form 20-F of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, i |
|
| July 28, 2022 |
description of our ordinary shares Exhibit 2.2 Description of Rights of Each Class of Securities Registered under Section 12 of the Securities Exchange Act of 1934 (the ?Exchange Act?) The following securities are registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended: Title of Each Class Trading Symbol Name of Each Exchange on Which Registered ordinary share, par value US$0.012 per share CJJD NASDAQ C |
|
| July 28, 2022 |
China Jo-Jo Drugstores Reports Fiscal Year 2022 Financial Results Exhibit 99.1 China Jo-Jo Drugstores Reports Fiscal Year 2022 Financial Results HANGZHOU, China, July 28, 2022 /PRNewswire/ - China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) (?Jo-Jo Drugstores? or the ?Company?), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced its financial results for the fis |
|
| July 28, 2022 |
Consent of Company’s current Independent Publicly Registered Accounting Firm, YCM CPA, Inc. EX-15.2 8 f20f2022ex15-2chinajojo.htm CONSENT OF COMPANY'S CURRENT INDEPENDENT PUBLICLY REGISTERED ACCOUNTING FIRM, YCM CPA, INC Exhibit 15.2 Consent of Independent Registered Public Accounting Firm China Jo-Jo Drugstores, Inc. We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-259692) and S-8 (No. 333-264505) of China Jo-Jo Drugstores, Inc. of |
|
| July 28, 2022 |
Section 906 Certification by the Corporation’s Chief Executive Officer and Chief Financial Officer * Exhibit 13.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual report on Form 20-F for the year ended March 31, 2022 (the ?Report?) of China Jo-Jo Drugstores, Inc. (the ?Company?) as filed with the Securities and Exchange Commission on the date hereof, we, Lei Liu, President and Chief Executive Offic |
|
| July 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July, 2022 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant?s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Zhej |
|
| July 28, 2022 |
Exhibit 15.1 Consent of Independent Registered Public Accounting Firm China Jo-Jo Drugstores, Inc. We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-259692) and S-8 (No. 333-264505) of China Jo-Jo Drugstores, Inc. of our report dated June 29, 2021, relating to the consolidated financial statements and schedules for the years ended March 31, 202 |
|
| July 28, 2022 |
Section 302 Certification by the Corporation’s Chief Executive Officer * Exhibit 12.1 CERTIFICATION BY THE PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Lei Liu, certify that: 1. I have reviewed this annual report on Form 20-F of China Jo-Jo Drugstores, Inc.; 2 Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in l |
|
| July 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F ? REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal year ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1 |
|
| May 31, 2022 |
Exhibit 99.1 May 27, 2022 Securities and Exchange Commission 100 F Street N.E. Washington, D.C. 20549 We have been furnished with a copy of the response to Form 6-K for the event that occurred on May 27, 2022, to be filed by our former client, China Jo-Jo Drugstores, Inc. We agree with the statements made in response to General Instruction B related to changes in registrant?s certifying accountant |
|
| May 31, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of May, 2022 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant?s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Zh |
|
| May 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of May 2022 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant?s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Zhejia |
|
| April 27, 2022 |
As filed with the Securities and Exchange Commission on April 27, 2022 As filed with the Securities and Exchange Commission on April 27, 2022 Registration No. |
|
| April 27, 2022 |
Amendment No. 2 to China Jo-Jo Drugstores, Inc. Amended and Restated 2010 Equity Incentive Plan Exhibit 10.2 AMENDMENT NO. 2 TO CHINA JO-JO DRUGSTORES, INC. AMENDED AND RESTATED 2010 EQUITY INCENTIVE PLAN China Jo-Jo Drugstores, Inc. (the ?Company?) previously approved and adopted the Amended and Restated 2010 Equity Incentive Plan (the ?Plan?) and Amendment No. 1 to encourage the Plan?s participants to acquire and hold stock in the Company as an added incentive to remain with the Company an |
|
| April 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2022 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant?s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Zhe |
|
| April 27, 2022 |
China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement Exhibit 99.1 China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement HANGZHOU, China, April 27, 2022 /PRNewswire/ - China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it receiv |
|
| April 27, 2022 |
China Jo-Jo Drugstores, Inc. Amended and Restated 2010 Equity Incentive Plan Exhibit 10.1 CHINA JO-JO DRUGSTORES, INC. AMENDED AND RESTATED 2010 EQUITY INCENTIVE PLAN 1. ESTABLISHMENT OF PLAN; DEFINITIONS 1.1 Purpose. The purpose of the China Jo-Jo Drugstores, Inc. Amended and Restated 2010 Equity Incentive Plan is to encourage certain officers, employees, directors, and consultants of China Jo-Jo Drugstores, Inc., a Nevada corporation (the ?Company?), to acquire and hold |
|
| April 27, 2022 |
Exhibit 107 Calculation of Filing Fee Tables .?S-8.? (Form Type) ????????China Jo-Jo Drugstores, Inc.?????????..? (Exact Name of Registrant as Specified in its Charter) ???????Not Applicable??????? (Translation of Registrant?s Name into English) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered(1) Propo |
|
| April 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of April, 2022 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant?s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Zhe |
|
| April 6, 2022 |
China Jo-Jo Drugstores, Inc. Announces 1-for-12 Reverse Stock Split Exhibit 99.1 China Jo-Jo Drugstores, Inc. Announces 1-for-12 Reverse Stock Split HANGZHOU, China, April 6, 2022 /PRNewswire/ ? China Jo-Jo Drugstores, Inc. (?Jo-Jo Drugstores? or the ?Company?) (Nasdaq: CJJD), a Cayman Islands company, reported that it expects to implement a 1-for-12 reverse stock split on its ordinary shares effective Thursday, April 7, 2022, with trading to begin on a split-adju |
|
| March 23, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March 2022 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant?s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Zhej |
|
| March 1, 2022 |
Exhibit 99.2 The Companies Act (Revised) Company Limited by Shares THE SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF CHINA JO-JO DRUGSTORES, INC. (adopted by a Special Resolution of the Shareholders of the Company dated 18 March 2022) Grand Cayman Cayman Islands conyers.com THE COMPANIES ACT (REVISED) EXEMPTED COMPANY LIMITED BY SHARES THE SECOND AMENDED AND RESTATED MEMORA |
|
| March 1, 2022 |
Exhibit 99.1 CHINA JO-JO DRUGSTORES, INC. Hai Wai Hai Tongxin Mansion, Floor 6, Gong Shu District, Hangzhou City, Zhejiang Province, P. R. China, 310008 NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS To be held on March 18, 2022 at 8:00 p.m. (Local Time) (or any adjournment or postponement thereof) To the Shareholders of China Jo-Jo Drugstores, Inc. Notice is hereby given that the Extraor |
|
| March 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of March, 2022 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant?s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Zhe |
|
| March 1, 2022 |
Exhibit 99.4 CHINA JO-JO DRUGSTORES, INC. CONTROL ID: REQUEST ID: IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS for the extraordinary general Meeting of Shareholders DATE: March 18, 2022 TIME: 8:00 A.M. EASTERN TIME LOCATION: Hai Wai Hai Tongxin Mansion Floor 6, Gong Shu District, Hangzhou City, Zhejiang Province, P. R. China, 310008 HOW TO REQUEST PAPER COPIES OF OUR MATERIALS PH |
|
| March 1, 2022 |
Exhibit 99.3 CHINA JO-JO DRUGSTORES, INC. THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS Extraordinary General MEETING OF SHAREHOLDERS ? March 18, 2022, AT 8:00 AM EASTERN TIME CONTROL ID: REQUEST ID: The undersigned shareholder of China Jo-Jo Drugstores, Inc., a Cayman Islands corporation (the ?Company?), hereby acknowledges receipt of the Notice of Annual Meeting of Shareholders and |
|
| January 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2022 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant?s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Zh |
|
| January 26, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2022 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant?s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Zh |
|
| January 26, 2022 |
China Jo-Jo Drugstores Granted Extension to Meet Nasdaq Minimum Bid Price Requirement Exhibit 99.1 China Jo-Jo Drugstores Granted Extension to Meet Nasdaq Minimum Bid Price Requirement HANGZHOU, China, January 26, 2022 /PRNewswire/ - China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that on Ja |
|
| January 21, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of January 2022 Commission File Number: 001-40724 CHINA JO-JO DRUGSTORES, INC. (Translation of registrant?s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Zh |
|
| January 21, 2022 |
China Jo-Jo Drugstores Reports First Half of Fiscal Year 2022 Financial Results Exhibit 99.1 China Jo-Jo Drugstores Reports First Half of Fiscal Year 2022 Financial Results HANGZHOU, China, January 21, 2022 /PRNewswire/ - China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) (?Jo-Jo Drugstores? or the ?Company?), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products, and healthcare provider in China, today announced its financial r |
|
| December 28, 2021 |
Exhibit 99.1 CHINA JO-JO DRUGSTORES, INC. Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City Zhejiang Province P. R. China, 310008 Telephone: +86-571-88219579 NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JANUARY 25, 2022 TO THE SHAREHOLDERS OF CHINA JO-JO DRUGSTORES, INC.: The Annual General Meeting of the shareholders for the fiscal year ended March 31, 2021 (t |
|
| December 28, 2021 |
Exhibit 99.3 CHINA JO-JO DRUGSTORES, INC. CONTROL ID: REQUEST ID: IMPORTANT NOTICE REGARDING THE AVAILABILITY OF PROXY MATERIALS for the Annual Meeting of Shareholders DATE: January 25, 2022 TIME: 9:00 P.M. EASTERN TIME LOCATION: Hai Wai Hai Tongxin Mansion Floor 6, Gong Shu District, Hangzhou City, Zhejiang Province, P. R. China, 310008 HOW TO REQUEST PAPER COPIES OF OUR MATERIALS PHONE: Call tol |
|
| December 28, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of December 2021 Commission File Number CHINA JO-JO DRUGSTORES, INC. (Translation of registrant?s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Zhejiang Pro |
|
| December 28, 2021 |
Exhibit 99.2 CHINA JO-JO DRUGSTORES, INC. THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS ANNUAL MEETING OF SHAREHOLDERS ? JANUARY 25, 2022, AT 9:00 PM EASTERN TIME CONTROL ID: REQUEST ID: The undersigned shareholder of China Jo-Jo Drugstores, Inc., a Cayman Islands corporation, (the ?Company?), hereby acknowledges receipt of the Notice of Annual Meeting of Shareholders and Proxy State |
|
| November 4, 2021 |
As filed with the Securities and Exchange Commission on November 4, 2021 As filed with the Securities and Exchange Commission on November 4, 2021 Registration No. |
|
| November 4, 2021 |
CORRESP 1 filename1.htm VIA EDGAR TRANSMISSION Stacey Peikin Lilyanna Peyser Securities and Exchange Commission Division of Corporation Finance Office of Trade & Services 100 F Street NE Washington, D.C. 20549-3561 November 4, 2021 Re: China Jo-Jo Drugstores, Inc. Registration Statement on Form F-3 Filed September 21, 2021 File No. 333-259692 Dear Ms. Peikin and Ms. Peyser: This letter is being fu |
|
| September 21, 2021 |
Power of Attorney (included in signature page of this registration statement) † As filed with the Securities and Exchange Commission on September 21, 2021 Registration No. |
|
| September 21, 2021 |
Form of Subordinated Debt Securities Indenture † Exhibit 4.8 CHINA JO-JO DRUGSTORES, INC. Issuer AND [TRUSTEE] Trustee INDENTURE Dated as of [?], 20[?] Subordinated Debt Securities TABLE OF CONTENTS ARTICLE 1 DEFINITIONS 1 Section 1.01 Definitions of Terms 1 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 4 Section 2.01 Designation and Terms of Securities 4 Section 2.02 Form of Securities and Trustee?s Cer |
|
| September 21, 2021 |
Form of Senior Debt Securities Indenture † Exhibit 4.7 CHINA JO-JO DRUGSTORES, INC. Issuer AND [TRUSTEE] Trustee INDENTURE Dated as of [?], 20[?] Senior Debt Securities Table of Contents Page ARTICLE 1 DEFINITIONS 1 Section 1.01 Definitions of Terms 1 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 5 Section 2.01 Designation and Terms of Securities 5 Section 2.02 Form of Securities and Trustee?s Cert |
|
| August 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 CHINA JO-JO DRUGSTORES, INC. (Exact name of registrant as specified in its charter) Cayman Islands 86-3436718 (State of Incorporation or Organization) (I.R.S. Employer Identification No.) Hai Wai H |
|
| July 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July, 2021 Commission File Number CHINA JO-JO DRUGSTORES, INC. (Translation of registrant?s name into English) Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City, Zhejiang Provin |
|
| July 30, 2021 |
China Jo-Jo Drugstores Completes Redomiciliation Merger Exhibit 99.1 China Jo-Jo Drugstores Completes Redomiciliation Merger HANGZHOU, China, July 30, 2021 /PRNewswire/ ? China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) (?Jo-Jo Drugstores? or the ?Company?), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that the redomiciliation merger to redomici |
|
| June 29, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 29, 2021 CHINA JO-JO DRUGSTORES, INC. (Exact name of Registrant as specified in charter) Nevada 001-34711 98-0557852 (State or other jurisdiction of Incorporation) (Commission Fi |
|
| June 29, 2021 |
China Jo-Jo Drugstores Reports Fiscal Year 2021 Financial Results Exhibit 99.1 China Jo-Jo Drugstores Reports Fiscal Year 2021 Financial Results HANGZHOU, China, June 29, 2021 /PRNewswire/ - China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) (?Jo-Jo Drugstores? or the ?Company?), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products, and healthcare provider in China, today announced its financial results for the fi |
|
| June 2, 2021 |
Filed Pursuant to Rule 424(b)(3) Registration No. 333-256176 CHINA JO-JO DRUGSTORES, INC. Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City People?s Republic of China 310008 June 2, 2021 Dear Stockholder: You are cordially invited to the special meeting of stockholders (the ?Special Meeting?) of China Jo-Jo Drugstores, Inc., a Nevada corporation (the ?Company?), to be held on Tu |
|
| May 27, 2021 |
China Jo-Jo Drugstores Holdings, Inc. Hai Wai Hai Tongxin Mansion Floor 6 Gong Shu District, Hangzhou City People?s Republic of China 310008 May 27, 2021 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Trade and Services 100 F Street, NE Washington, D.C. 20549 Attention: Katherine Bagley Re: China Jo-Jo Drugstores Holdings, Inc. Registration Statement on |
|
| May 26, 2021 |
As filed with the Securities and Exchange Commission on May 26, 2021 As filed with the Securities and Exchange Commission on May 26, 2021 Registration No. |
|
| May 17, 2021 |
EXHIBIT 21.1 China Jo-Jo Drugstores Holdings, Inc. Subsidiaries of Registrant None. |
|
| May 17, 2021 |
Exhibit 3.1 The Companies Act (Revised) Company Limited by Shares AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF CHINA JO-JO DRUGSTORES HOLDINGS, INC. (adopted by a Special Resolution of the Shareholders of the Company dated 12 May 2021 Grand Cayman Cayman Islands conyers.com THE COMPANIES ACT (REVISED) EXEMPTED COMPANY LIMITED BY SHARES AMENDED AND RESTATED MEMORANDUM OF ASSOCIATI |
|
| May 17, 2021 |
As filed with the Securities and Exchange Commission on May 17, 2021 Registration No. |
|
| May 17, 2021 |
Exhibit 99.1 CHINA JO-JO DRUGSTORES, INC. THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS Special MEETING OF STOCKHOLDERS ? , 2021 AT ET ( , 2021 AT BEIJING TIME) CONTROL ID: REQUEST ID: The undersigned hereby appoints Lei Liu as proxy of the undersigned, with full power of substitution, to vote all the shares of common stock of China Jo-Jo Drugstores, Inc. held of record by the unders |
